Search Results

Press Releases

October 11, 2024

·

6 min read

Hemostemix Announces Trademark Granted by Switzerland and Interest Payment

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark

June 11, 2024

·

6 min read

Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments

Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent (“LOI”) with CytoImmune Therapuetics

June 3, 2024

·

10 min read

Press Releases

Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement

October 31, 2024

·

10 min read

Policy

Hemostemix Announces Engagement of Oak Hill Asset Management Inc.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. (“OHAM”), an Exempt Market Dealer to provide capital markets advice related to the Company’s capital markets strategy.

March 8, 2024

·

7 min read

Hemostemix Clarifies its October 3, 2023 News Release

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to like to clarify its press release of October 3, 2023.

January 2, 2024

·

5 min read

Drug Development

Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Journal of Biomedical Research and Environmental Sciences

February 6, 2024

·

7 min read

Press Releases

Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01

August 2, 2024

·

10 min read

Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it incorporated Hemostemix Quebec Inc. and has applied for grant funding of $6 Million, to locate production of ACP-01 in Montreal.

August 29, 2023

·

5 min read

Hemostemix Announces Private Placement.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce a new private placement of $325,125, the sale of approximately 2.7 Million Units priced at $0.12 each.

September 28, 2023

·

7 min read